Track topics on Twitter Track topics that are important to you
Tecovirimat (TPOXX) provides a treatment option should smallpox ever be used as a bioweapon and is the first product to be awarded a material threat medical countermeasure priority review voucher.
Original Article: FDA Approves Tecovirimat, First Drug for Smallpox TreatmentNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...